Back to Authors

Wang, Xueyin

https://orcid.org/0000-0003-4461-324X

A5101632808 | I4210118611

Mayo Clinic

A2 Biotherapeutics, Inc., Agoura Hills, CA, USA

Citations 2

229 A2B530, an autologous CEA-directed Tmod T-cell therapy with an inhibitory receptor gated by HLA-A*02 to target colorectal, pancreatic, and lung cancer

Regular and Young Investigator Award Abstracts | November 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: A242-A242

10.1136/jitc-2022-sitc2022.0229

77 An NGS assay to identify HLA loss of heterozygosity for future CEA and MSLN logic-gated CAR-T solid tumor protocols designed for reduced on-target, off-tumor toxicity

Regular and Young Investigator Award Abstracts | November 7, 2022 | Volume: No volume available | Issue: No issue available | Pages: A83-A83

10.1136/jitc-2022-sitc2022.0077